Semen volume, density, motility, viability, and morphology of spermatozoa, and serum and seminal plasma levels of the hormones FSH, LH, prolactin, progesterone, 17-a-hydroxyprogesterone, androstenedione, testosterone, dihidrotestosterone, and estradiol 17-p have been measured in 22 men subjected to experimental hyperprolactinaemia by the simultaneous administration of the antidopaminergic drugs metoclopramide and sulpiride. Hyperprolactinaemia produces a decrease of semen volume and seminal quality. In hyperprolactinaemia, normozoospermic patients had an increase of serum androstenedione. In both norrno- and oligozoospermic groups, a decrease of serum testosterone was observed. Hyperprolactinaemia also causes an inhibition of the secretory activity of the accessory sexual glands of the reproductive tract, as well as either a decrease of 17-ketosteroid reductase or an increase of 17-a-hydroxysteroid dehydrogenase (enzymes that participate in the androstenedione-testosterone interconversions). This change appears to be more pronounced in individuals with good seminal quality. © 1982, Informa UK Ltd. All rights reserved.
CITATION STYLE
García Díez, L. C., & Gonzalez Buitrago, J. M. (1982). Semen Characteristics and Serum and Seminal Plasma Hormones in Drug-Induced Hyperprolactinaemia. Archives of Andrology, 9(4), 311–317. https://doi.org/10.3109/01485018208990257
Mendeley helps you to discover research relevant for your work.